Form 8-K - Current report:
SEC Accession No. 0001157523-21-000192
Filing Date
2021-02-16
Accepted
2021-02-16 16:22:31
Documents
13
Period of Report
2021-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a52380031.htm   iXBRL 8-K 25356
2 EXHIBIT 99.1 a52380031ex99_1.htm EX-99.1 3874
  Complete submission text file 0001157523-21-000192.txt   169448

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA usna-20210216.xsd EX-101.SCH 4186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20210216_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20210216_pre.xml EX-101.PRE 16824
6 EXTRACTED XBRL INSTANCE DOCUMENT a52380031_htm.xml XML 4086
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 21638933
SIC: 2833 Medicinal Chemicals & Botanical Products